nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—Parkinson's disease—Memantine—Alzheimer's disease	0.337	0.5	CpDpCtD
Gabapentin—Parkinson's disease—Rivastigmine—Alzheimer's disease	0.337	0.5	CpDpCtD
Gabapentin—CACNA1B—forebrain—Alzheimer's disease	0.00353	0.0902	CbGeAlD
Gabapentin—CACNA1B—telencephalon—Alzheimer's disease	0.00325	0.083	CbGeAlD
Gabapentin—CACNA2D2—telencephalon—Alzheimer's disease	0.00234	0.0598	CbGeAlD
Gabapentin—CACNA1B—nervous system—Alzheimer's disease	0.00192	0.049	CbGeAlD
Gabapentin—CACNA1B—central nervous system—Alzheimer's disease	0.00185	0.0472	CbGeAlD
Gabapentin—CACNA2D1—forebrain—Alzheimer's disease	0.00183	0.0468	CbGeAlD
Gabapentin—CACNA1B—cerebellum—Alzheimer's disease	0.0018	0.0461	CbGeAlD
Gabapentin—ADORA1—forebrain—Alzheimer's disease	0.00177	0.0451	CbGeAlD
Gabapentin—ADORA1—telencephalon—Alzheimer's disease	0.00162	0.0415	CbGeAlD
Gabapentin—BCAT1—nervous system—Alzheimer's disease	0.00151	0.0385	CbGeAlD
Gabapentin—CACNA1B—brain—Alzheimer's disease	0.00147	0.0374	CbGeAlD
Gabapentin—BCAT1—central nervous system—Alzheimer's disease	0.00145	0.0371	CbGeAlD
Gabapentin—BCAT1—cerebellum—Alzheimer's disease	0.00142	0.0362	CbGeAlD
Gabapentin—CACNA2D2—nervous system—Alzheimer's disease	0.00138	0.0353	CbGeAlD
Gabapentin—CACNA2D2—central nervous system—Alzheimer's disease	0.00133	0.034	CbGeAlD
Gabapentin—CACNA2D2—cerebellum—Alzheimer's disease	0.0013	0.0332	CbGeAlD
Gabapentin—BCAT1—brain—Alzheimer's disease	0.00115	0.0294	CbGeAlD
Gabapentin—CACNA2D2—brain—Alzheimer's disease	0.00106	0.027	CbGeAlD
Gabapentin—CACNA2D1—nervous system—Alzheimer's disease	0.000994	0.0254	CbGeAlD
Gabapentin—ADORA1—nervous system—Alzheimer's disease	0.000959	0.0245	CbGeAlD
Gabapentin—CACNA2D1—central nervous system—Alzheimer's disease	0.000957	0.0245	CbGeAlD
Gabapentin—CACNA2D1—cerebellum—Alzheimer's disease	0.000936	0.0239	CbGeAlD
Gabapentin—ADORA1—central nervous system—Alzheimer's disease	0.000924	0.0236	CbGeAlD
Gabapentin—ADORA1—cerebellum—Alzheimer's disease	0.000903	0.0231	CbGeAlD
Gabapentin—CACNA2D1—brain—Alzheimer's disease	0.00076	0.0194	CbGeAlD
Gabapentin—ADORA1—brain—Alzheimer's disease	0.000733	0.0187	CbGeAlD
Gabapentin—CACNA2D2—Neuronal System—CHRNA7—Alzheimer's disease	0.000301	0.00489	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—GRIK1—Alzheimer's disease	0.000301	0.00489	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—PRKCG—Alzheimer's disease	0.000301	0.00489	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—ACHE—Alzheimer's disease	0.0003	0.00487	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000298	0.00484	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—CHRNA4—Alzheimer's disease	0.000296	0.00481	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000282	0.00458	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—BCHE—Alzheimer's disease	0.000261	0.00424	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—CALM1—Alzheimer's disease	0.00026	0.00423	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.000259	0.00421	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—DHCR24—Alzheimer's disease	0.000256	0.00416	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000256	0.00416	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—CHAT—Alzheimer's disease	0.000256	0.00416	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—GRIK2—Alzheimer's disease	0.000256	0.00416	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—DLG4—Alzheimer's disease	0.000255	0.00414	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—GRIN2B—Alzheimer's disease	0.000249	0.00404	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—INS—Alzheimer's disease	0.000249	0.00404	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—PLCB1—Alzheimer's disease	0.000246	0.004	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.000242	0.00393	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000238	0.00386	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	0.000235	0.00383	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—GRIA1—Alzheimer's disease	0.000228	0.00371	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000226	0.00367	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.00022	0.00358	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CA4—Alzheimer's disease	0.000218	0.00354	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—CHRNB2—Alzheimer's disease	0.000216	0.00351	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.000215	0.0035	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000213	0.00346	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—GAL—Alzheimer's disease	0.000211	0.00342	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000206	0.00334	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GAPDHS—Alzheimer's disease	0.000205	0.00333	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.000202	0.00328	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—CHRNB2—Alzheimer's disease	0.000199	0.00324	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—CST3—Alzheimer's disease	0.000199	0.00324	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—ACHE—Alzheimer's disease	0.000198	0.00322	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—CHRNA4—Alzheimer's disease	0.000196	0.00319	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—INS—Alzheimer's disease	0.000196	0.00318	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ATP5A1—Alzheimer's disease	0.000194	0.00315	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TP53—Alzheimer's disease	0.000192	0.00312	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PLD3—Alzheimer's disease	0.000185	0.00301	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—PYY—Alzheimer's disease	0.000184	0.00299	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—PRKCG—Alzheimer's disease	0.000182	0.00296	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—CRH—Alzheimer's disease	0.000181	0.00294	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HSD17B10—Alzheimer's disease	0.000178	0.00288	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.000176	0.00286	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—BCHE—Alzheimer's disease	0.000173	0.00281	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—NPS—Alzheimer's disease	0.000172	0.00279	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP46A1—Alzheimer's disease	0.000171	0.00278	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—DLG4—Alzheimer's disease	0.000169	0.00274	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—SLC6A4—Alzheimer's disease	0.000168	0.00273	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.000168	0.00272	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—NPY—Alzheimer's disease	0.000165	0.00269	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ND1—Alzheimer's disease	0.000165	0.00268	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—GRIN2B—Alzheimer's disease	0.000165	0.00268	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—PLCB1—Alzheimer's disease	0.000163	0.00265	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—CALM1—Alzheimer's disease	0.000158	0.00256	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000157	0.00256	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—DHCR24—Alzheimer's disease	0.000155	0.00252	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—HTR6—Alzheimer's disease	0.000154	0.0025	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—SST—Alzheimer's disease	0.000144	0.00235	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—APP—Alzheimer's disease	0.000141	0.00229	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—NGFR—Alzheimer's disease	0.00014	0.00228	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000136	0.00221	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—CREB1—Alzheimer's disease	0.000135	0.00219	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CA4—Alzheimer's disease	0.000132	0.00214	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000132	0.00214	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GAL—Alzheimer's disease	0.000128	0.00207	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PPARGC1A—Alzheimer's disease	0.000126	0.00204	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GAPDHS—Alzheimer's disease	0.000124	0.00202	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—PRKCG—Alzheimer's disease	0.000121	0.00196	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.00012	0.00196	CbGpPWpGaD
Gabapentin—Tachycardia—Galantamine—Alzheimer's disease	0.000118	0.000522	CcSEcCtD
Gabapentin—Oedema peripheral—Memantine—Alzheimer's disease	0.000118	0.000522	CcSEcCtD
Gabapentin—Connective tissue disorder—Memantine—Alzheimer's disease	0.000118	0.000521	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—ATP5A1—Alzheimer's disease	0.000118	0.00191	CbGpPWpGaD
Gabapentin—Rhinitis—Rivastigmine—Alzheimer's disease	0.000117	0.00052	CcSEcCtD
Gabapentin—Skin disorder—Galantamine—Alzheimer's disease	0.000117	0.00052	CcSEcCtD
Gabapentin—Urethral disorder—Memantine—Alzheimer's disease	0.000117	0.00052	CcSEcCtD
Gabapentin—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000117	0.000519	CcSEcCtD
Gabapentin—Hepatitis—Rivastigmine—Alzheimer's disease	0.000117	0.000519	CcSEcCtD
Gabapentin—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000117	0.000517	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.000117	0.00189	CbGpPWpGaD
Gabapentin—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000117	0.000516	CcSEcCtD
Gabapentin—Hallucination—Rivastigmine—Alzheimer's disease	0.000117	0.000516	CcSEcCtD
Gabapentin—Alopecia—Donepezil—Alzheimer's disease	0.000117	0.000516	CcSEcCtD
Gabapentin—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000116	0.000515	CcSEcCtD
Gabapentin—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000116	0.000512	CcSEcCtD
Gabapentin—Mental disorder—Donepezil—Alzheimer's disease	0.000116	0.000511	CcSEcCtD
Gabapentin—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000115	0.000511	CcSEcCtD
Gabapentin—Visual impairment—Memantine—Alzheimer's disease	0.000115	0.000511	CcSEcCtD
Gabapentin—Anorexia—Galantamine—Alzheimer's disease	0.000115	0.00051	CcSEcCtD
Gabapentin—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000115	0.00051	CcSEcCtD
Gabapentin—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000115	0.000508	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.000115	0.00187	CbGpPWpGaD
Gabapentin—Erythema—Donepezil—Alzheimer's disease	0.000115	0.000508	CcSEcCtD
Gabapentin—Malnutrition—Donepezil—Alzheimer's disease	0.000115	0.000508	CcSEcCtD
Gabapentin—Erythema multiforme—Memantine—Alzheimer's disease	0.000113	0.000501	CcSEcCtD
Gabapentin—Flatulence—Donepezil—Alzheimer's disease	0.000113	0.000501	CcSEcCtD
Gabapentin—Hypotension—Galantamine—Alzheimer's disease	0.000113	0.0005	CcSEcCtD
Gabapentin—Visual impairment—Rivastigmine—Alzheimer's disease	0.000113	0.0005	CcSEcCtD
Gabapentin—Tension—Donepezil—Alzheimer's disease	0.000113	0.000499	CcSEcCtD
Gabapentin—Dysgeusia—Donepezil—Alzheimer's disease	0.000112	0.000498	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PLD3—Alzheimer's disease	0.000112	0.00182	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000112	0.00182	CbGpPWpGaD
Gabapentin—Eye disorder—Memantine—Alzheimer's disease	0.000112	0.000495	CcSEcCtD
Gabapentin—Tinnitus—Memantine—Alzheimer's disease	0.000112	0.000494	CcSEcCtD
Gabapentin—Nervousness—Donepezil—Alzheimer's disease	0.000111	0.000494	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—PRKCG—Alzheimer's disease	0.000111	0.00181	CbGpPWpGaD
Gabapentin—Cardiac disorder—Memantine—Alzheimer's disease	0.000111	0.000492	CcSEcCtD
Gabapentin—Back pain—Donepezil—Alzheimer's disease	0.000111	0.000492	CcSEcCtD
Gabapentin—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000111	0.00049	CcSEcCtD
Gabapentin—Muscle spasms—Donepezil—Alzheimer's disease	0.00011	0.000489	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00011	0.000488	CcSEcCtD
Gabapentin—Eye disorder—Rivastigmine—Alzheimer's disease	0.000109	0.000485	CcSEcCtD
Gabapentin—Insomnia—Galantamine—Alzheimer's disease	0.000109	0.000484	CcSEcCtD
Gabapentin—Tinnitus—Rivastigmine—Alzheimer's disease	0.000109	0.000484	CcSEcCtD
Gabapentin—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000109	0.000481	CcSEcCtD
Gabapentin—Paraesthesia—Galantamine—Alzheimer's disease	0.000109	0.000481	CcSEcCtD
Gabapentin—Vision blurred—Donepezil—Alzheimer's disease	0.000108	0.000479	CcSEcCtD
Gabapentin—Immune system disorder—Memantine—Alzheimer's disease	0.000108	0.000479	CcSEcCtD
Gabapentin—Mediastinal disorder—Memantine—Alzheimer's disease	0.000108	0.000478	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—HSD17B10—Alzheimer's disease	0.000108	0.00175	CbGpPWpGaD
Gabapentin—Tremor—Donepezil—Alzheimer's disease	0.000108	0.000476	CcSEcCtD
Gabapentin—Somnolence—Galantamine—Alzheimer's disease	0.000107	0.000476	CcSEcCtD
Gabapentin—Chills—Memantine—Alzheimer's disease	0.000107	0.000476	CcSEcCtD
Gabapentin—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000106	0.000472	CcSEcCtD
Gabapentin—Dyspepsia—Galantamine—Alzheimer's disease	0.000106	0.000471	CcSEcCtD
Gabapentin—BCAT1—Metabolism—CHAT—Alzheimer's disease	0.000106	0.00173	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—TPI1—Alzheimer's disease	0.000106	0.00173	CbGpPWpGaD
Gabapentin—Anaemia—Donepezil—Alzheimer's disease	0.000106	0.00047	CcSEcCtD
Gabapentin—Alopecia—Memantine—Alzheimer's disease	0.000106	0.000468	CcSEcCtD
Gabapentin—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000106	0.000467	CcSEcCtD
Gabapentin—Agitation—Donepezil—Alzheimer's disease	0.000105	0.000467	CcSEcCtD
Gabapentin—Chills—Rivastigmine—Alzheimer's disease	0.000105	0.000465	CcSEcCtD
Gabapentin—Decreased appetite—Galantamine—Alzheimer's disease	0.000105	0.000465	CcSEcCtD
Gabapentin—Mental disorder—Memantine—Alzheimer's disease	0.000105	0.000464	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000104	0.000462	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—CALM1—Alzheimer's disease	0.000104	0.0017	CbGpPWpGaD
Gabapentin—Malnutrition—Memantine—Alzheimer's disease	0.000104	0.000461	CcSEcCtD
Gabapentin—Fatigue—Galantamine—Alzheimer's disease	0.000104	0.000461	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PYY—Alzheimer's disease	0.000104	0.00169	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP46A1—Alzheimer's disease	0.000104	0.00168	CbGpPWpGaD
Gabapentin—Malaise—Donepezil—Alzheimer's disease	0.000104	0.000458	CcSEcCtD
Gabapentin—Alopecia—Rivastigmine—Alzheimer's disease	0.000103	0.000458	CcSEcCtD
Gabapentin—Constipation—Galantamine—Alzheimer's disease	0.000103	0.000458	CcSEcCtD
Gabapentin—Vertigo—Donepezil—Alzheimer's disease	0.000103	0.000457	CcSEcCtD
Gabapentin—Syncope—Donepezil—Alzheimer's disease	0.000103	0.000456	CcSEcCtD
Gabapentin—Flatulence—Memantine—Alzheimer's disease	0.000103	0.000455	CcSEcCtD
Gabapentin—Mental disorder—Rivastigmine—Alzheimer's disease	0.000103	0.000454	CcSEcCtD
Gabapentin—Tension—Memantine—Alzheimer's disease	0.000102	0.000453	CcSEcCtD
Gabapentin—Dysgeusia—Memantine—Alzheimer's disease	0.000102	0.000452	CcSEcCtD
Gabapentin—BCAT1—Metabolism—MAOB—Alzheimer's disease	0.000102	0.00166	CbGpPWpGaD
Gabapentin—Erythema—Rivastigmine—Alzheimer's disease	0.000102	0.000451	CcSEcCtD
Gabapentin—Malnutrition—Rivastigmine—Alzheimer's disease	0.000102	0.000451	CcSEcCtD
Gabapentin—Nervousness—Memantine—Alzheimer's disease	0.000101	0.000448	CcSEcCtD
Gabapentin—Loss of consciousness—Donepezil—Alzheimer's disease	0.000101	0.000447	CcSEcCtD
Gabapentin—Back pain—Memantine—Alzheimer's disease	0.000101	0.000446	CcSEcCtD
Gabapentin—Flatulence—Rivastigmine—Alzheimer's disease	0.0001	0.000445	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—NPY—Alzheimer's disease	0.0001	0.00163	CbGpPWpGaD
Gabapentin—Cough—Donepezil—Alzheimer's disease	0.0001	0.000443	CcSEcCtD
Gabapentin—Tension—Rivastigmine—Alzheimer's disease	0.0001	0.000443	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—ND1—Alzheimer's disease	0.0001	0.00162	CbGpPWpGaD
Gabapentin—Dysgeusia—Rivastigmine—Alzheimer's disease	9.98e-05	0.000442	CcSEcCtD
Gabapentin—Feeling abnormal—Galantamine—Alzheimer's disease	9.96e-05	0.000441	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—IAPP—Alzheimer's disease	9.96e-05	0.00162	CbGpPWpGaD
Gabapentin—Convulsion—Donepezil—Alzheimer's disease	9.95e-05	0.00044	CcSEcCtD
Gabapentin—Hypertension—Donepezil—Alzheimer's disease	9.91e-05	0.000439	CcSEcCtD
Gabapentin—Nervousness—Rivastigmine—Alzheimer's disease	9.9e-05	0.000438	CcSEcCtD
Gabapentin—Gastrointestinal pain—Galantamine—Alzheimer's disease	9.88e-05	0.000438	CcSEcCtD
Gabapentin—Back pain—Rivastigmine—Alzheimer's disease	9.86e-05	0.000437	CcSEcCtD
Gabapentin—Vision blurred—Memantine—Alzheimer's disease	9.82e-05	0.000435	CcSEcCtD
Gabapentin—BCAT1—Metabolism—GAPDH—Alzheimer's disease	9.82e-05	0.00159	CbGpPWpGaD
Gabapentin—Muscle spasms—Rivastigmine—Alzheimer's disease	9.8e-05	0.000434	CcSEcCtD
Gabapentin—Myalgia—Donepezil—Alzheimer's disease	9.77e-05	0.000433	CcSEcCtD
Gabapentin—Arthralgia—Donepezil—Alzheimer's disease	9.77e-05	0.000433	CcSEcCtD
Gabapentin—Chest pain—Donepezil—Alzheimer's disease	9.77e-05	0.000433	CcSEcCtD
Gabapentin—Tremor—Memantine—Alzheimer's disease	9.76e-05	0.000432	CcSEcCtD
Gabapentin—Anxiety—Donepezil—Alzheimer's disease	9.74e-05	0.000431	CcSEcCtD
Gabapentin—Ill-defined disorder—Memantine—Alzheimer's disease	9.67e-05	0.000428	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—CRH—Alzheimer's disease	9.67e-05	0.00157	CbGpPWpGaD
Gabapentin—Discomfort—Donepezil—Alzheimer's disease	9.65e-05	0.000427	CcSEcCtD
Gabapentin—Anaemia—Memantine—Alzheimer's disease	9.63e-05	0.000427	CcSEcCtD
Gabapentin—Vision blurred—Rivastigmine—Alzheimer's disease	9.61e-05	0.000425	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—LEP—Alzheimer's disease	9.59e-05	0.00156	CbGpPWpGaD
Gabapentin—Agitation—Memantine—Alzheimer's disease	9.58e-05	0.000424	CcSEcCtD
Gabapentin—Dry mouth—Donepezil—Alzheimer's disease	9.56e-05	0.000423	CcSEcCtD
Gabapentin—Body temperature increased—Galantamine—Alzheimer's disease	9.56e-05	0.000423	CcSEcCtD
Gabapentin—Abdominal pain—Galantamine—Alzheimer's disease	9.56e-05	0.000423	CcSEcCtD
Gabapentin—Tremor—Rivastigmine—Alzheimer's disease	9.55e-05	0.000423	CcSEcCtD
Gabapentin—BCAT1—Metabolism—A2M—Alzheimer's disease	9.48e-05	0.00154	CbGpPWpGaD
Gabapentin—Ill-defined disorder—Rivastigmine—Alzheimer's disease	9.46e-05	0.000419	CcSEcCtD
Gabapentin—Confusional state—Donepezil—Alzheimer's disease	9.45e-05	0.000418	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PYY—Alzheimer's disease	9.44e-05	0.00153	CbGpPWpGaD
Gabapentin—Anaemia—Rivastigmine—Alzheimer's disease	9.42e-05	0.000417	CcSEcCtD
Gabapentin—Malaise—Memantine—Alzheimer's disease	9.4e-05	0.000416	CcSEcCtD
Gabapentin—Agitation—Rivastigmine—Alzheimer's disease	9.37e-05	0.000415	CcSEcCtD
Gabapentin—Oedema—Donepezil—Alzheimer's disease	9.37e-05	0.000415	CcSEcCtD
Gabapentin—Vertigo—Memantine—Alzheimer's disease	9.36e-05	0.000415	CcSEcCtD
Gabapentin—Syncope—Memantine—Alzheimer's disease	9.35e-05	0.000414	CcSEcCtD
Gabapentin—Leukopenia—Memantine—Alzheimer's disease	9.33e-05	0.000413	CcSEcCtD
Gabapentin—Infection—Donepezil—Alzheimer's disease	9.31e-05	0.000412	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—CCR5—Alzheimer's disease	9.3e-05	0.00151	CbGpPWpGaD
Gabapentin—Shock—Donepezil—Alzheimer's disease	9.22e-05	0.000408	CcSEcCtD
Gabapentin—Palpitations—Memantine—Alzheimer's disease	9.21e-05	0.000408	CcSEcCtD
Gabapentin—Malaise—Rivastigmine—Alzheimer's disease	9.19e-05	0.000407	CcSEcCtD
Gabapentin—Nervous system disorder—Donepezil—Alzheimer's disease	9.19e-05	0.000407	CcSEcCtD
Gabapentin—Thrombocytopenia—Donepezil—Alzheimer's disease	9.17e-05	0.000406	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—NPS—Alzheimer's disease	9.16e-05	0.00149	CbGpPWpGaD
Gabapentin—Vertigo—Rivastigmine—Alzheimer's disease	9.16e-05	0.000406	CcSEcCtD
Gabapentin—Loss of consciousness—Memantine—Alzheimer's disease	9.16e-05	0.000406	CcSEcCtD
Gabapentin—Syncope—Rivastigmine—Alzheimer's disease	9.14e-05	0.000405	CcSEcCtD
Gabapentin—Cough—Memantine—Alzheimer's disease	9.09e-05	0.000403	CcSEcCtD
Gabapentin—Hyperhidrosis—Donepezil—Alzheimer's disease	9.06e-05	0.000401	CcSEcCtD
Gabapentin—Convulsion—Memantine—Alzheimer's disease	9.03e-05	0.0004	CcSEcCtD
Gabapentin—Palpitations—Rivastigmine—Alzheimer's disease	9.01e-05	0.000399	CcSEcCtD
Gabapentin—Hypertension—Memantine—Alzheimer's disease	9e-05	0.000398	CcSEcCtD
Gabapentin—Loss of consciousness—Rivastigmine—Alzheimer's disease	8.96e-05	0.000397	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—NOS2—Alzheimer's disease	8.94e-05	0.00145	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—CREB1—Alzheimer's disease	8.93e-05	0.00145	CbGpPWpGaD
Gabapentin—Anorexia—Donepezil—Alzheimer's disease	8.93e-05	0.000395	CcSEcCtD
Gabapentin—Hypersensitivity—Galantamine—Alzheimer's disease	8.91e-05	0.000394	CcSEcCtD
Gabapentin—Cough—Rivastigmine—Alzheimer's disease	8.9e-05	0.000394	CcSEcCtD
Gabapentin—Chest pain—Memantine—Alzheimer's disease	8.87e-05	0.000393	CcSEcCtD
Gabapentin—Arthralgia—Memantine—Alzheimer's disease	8.87e-05	0.000393	CcSEcCtD
Gabapentin—Myalgia—Memantine—Alzheimer's disease	8.87e-05	0.000393	CcSEcCtD
Gabapentin—Anxiety—Memantine—Alzheimer's disease	8.84e-05	0.000391	CcSEcCtD
Gabapentin—Convulsion—Rivastigmine—Alzheimer's disease	8.83e-05	0.000391	CcSEcCtD
Gabapentin—Hypertension—Rivastigmine—Alzheimer's disease	8.8e-05	0.00039	CcSEcCtD
Gabapentin—Discomfort—Memantine—Alzheimer's disease	8.77e-05	0.000388	CcSEcCtD
Gabapentin—Hypotension—Donepezil—Alzheimer's disease	8.75e-05	0.000388	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—SST—Alzheimer's disease	8.74e-05	0.00142	CbGpPWpGaD
Gabapentin—Myalgia—Rivastigmine—Alzheimer's disease	8.68e-05	0.000384	CcSEcCtD
Gabapentin—Chest pain—Rivastigmine—Alzheimer's disease	8.68e-05	0.000384	CcSEcCtD
Gabapentin—Arthralgia—Rivastigmine—Alzheimer's disease	8.68e-05	0.000384	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—HTR6—Alzheimer's disease	8.68e-05	0.00141	CbGpPWpGaD
Gabapentin—Dry mouth—Memantine—Alzheimer's disease	8.68e-05	0.000384	CcSEcCtD
Gabapentin—Asthenia—Galantamine—Alzheimer's disease	8.67e-05	0.000384	CcSEcCtD
Gabapentin—Anxiety—Rivastigmine—Alzheimer's disease	8.65e-05	0.000383	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	8.64e-05	0.0014	CbGpPWpGaD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	8.62e-05	0.000382	CcSEcCtD
Gabapentin—Confusional state—Memantine—Alzheimer's disease	8.58e-05	0.00038	CcSEcCtD
Gabapentin—Discomfort—Rivastigmine—Alzheimer's disease	8.58e-05	0.00038	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	8.53e-05	0.000378	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—APP—Alzheimer's disease	8.52e-05	0.00138	CbGpPWpGaD
Gabapentin—Oedema—Memantine—Alzheimer's disease	8.51e-05	0.000377	CcSEcCtD
Gabapentin—Dry mouth—Rivastigmine—Alzheimer's disease	8.49e-05	0.000376	CcSEcCtD
Gabapentin—Insomnia—Donepezil—Alzheimer's disease	8.47e-05	0.000375	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	8.45e-05	0.00137	CbGpPWpGaD
Gabapentin—Infection—Memantine—Alzheimer's disease	8.45e-05	0.000374	CcSEcCtD
Gabapentin—Paraesthesia—Donepezil—Alzheimer's disease	8.41e-05	0.000372	CcSEcCtD
Gabapentin—Confusional state—Rivastigmine—Alzheimer's disease	8.39e-05	0.000371	CcSEcCtD
Gabapentin—Shock—Memantine—Alzheimer's disease	8.37e-05	0.000371	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—PPARG—Alzheimer's disease	8.36e-05	0.00136	CbGpPWpGaD
Gabapentin—Dyspnoea—Donepezil—Alzheimer's disease	8.35e-05	0.00037	CcSEcCtD
Gabapentin—Nervous system disorder—Memantine—Alzheimer's disease	8.34e-05	0.000369	CcSEcCtD
Gabapentin—Somnolence—Donepezil—Alzheimer's disease	8.33e-05	0.000369	CcSEcCtD
Gabapentin—Thrombocytopenia—Memantine—Alzheimer's disease	8.33e-05	0.000369	CcSEcCtD
Gabapentin—Oedema—Rivastigmine—Alzheimer's disease	8.32e-05	0.000368	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—GSK3B—Alzheimer's disease	8.31e-05	0.00135	CbGpPWpGaD
Gabapentin—Tachycardia—Memantine—Alzheimer's disease	8.3e-05	0.000368	CcSEcCtD
Gabapentin—Diarrhoea—Galantamine—Alzheimer's disease	8.27e-05	0.000366	CcSEcCtD
Gabapentin—Infection—Rivastigmine—Alzheimer's disease	8.27e-05	0.000366	CcSEcCtD
Gabapentin—Skin disorder—Memantine—Alzheimer's disease	8.26e-05	0.000366	CcSEcCtD
Gabapentin—BCAT1—Metabolism—ACHE—Alzheimer's disease	8.25e-05	0.00134	CbGpPWpGaD
Gabapentin—Dyspepsia—Donepezil—Alzheimer's disease	8.25e-05	0.000365	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—CREB1—Alzheimer's disease	8.24e-05	0.00134	CbGpPWpGaD
Gabapentin—Hyperhidrosis—Memantine—Alzheimer's disease	8.22e-05	0.000364	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—CDK5—Alzheimer's disease	8.19e-05	0.00133	CbGpPWpGaD
Gabapentin—Shock—Rivastigmine—Alzheimer's disease	8.19e-05	0.000362	CcSEcCtD
Gabapentin—Nervous system disorder—Rivastigmine—Alzheimer's disease	8.16e-05	0.000361	CcSEcCtD
Gabapentin—BCAT1—Metabolism—INPP5D—Alzheimer's disease	8.15e-05	0.00132	CbGpPWpGaD
Gabapentin—Thrombocytopenia—Rivastigmine—Alzheimer's disease	8.15e-05	0.000361	CcSEcCtD
Gabapentin—Decreased appetite—Donepezil—Alzheimer's disease	8.14e-05	0.000361	CcSEcCtD
Gabapentin—Tachycardia—Rivastigmine—Alzheimer's disease	8.12e-05	0.00036	CcSEcCtD
Gabapentin—Anorexia—Memantine—Alzheimer's disease	8.11e-05	0.000359	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Donepezil—Alzheimer's disease	8.09e-05	0.000358	CcSEcCtD
Gabapentin—Skin disorder—Rivastigmine—Alzheimer's disease	8.08e-05	0.000358	CcSEcCtD
Gabapentin—Fatigue—Donepezil—Alzheimer's disease	8.08e-05	0.000358	CcSEcCtD
Gabapentin—Hyperhidrosis—Rivastigmine—Alzheimer's disease	8.04e-05	0.000356	CcSEcCtD
Gabapentin—Pain—Donepezil—Alzheimer's disease	8.01e-05	0.000355	CcSEcCtD
Gabapentin—Constipation—Donepezil—Alzheimer's disease	8.01e-05	0.000355	CcSEcCtD
Gabapentin—Dizziness—Galantamine—Alzheimer's disease	7.99e-05	0.000354	CcSEcCtD
Gabapentin—Hypotension—Memantine—Alzheimer's disease	7.95e-05	0.000352	CcSEcCtD
Gabapentin—Anorexia—Rivastigmine—Alzheimer's disease	7.93e-05	0.000351	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—HTR6—Alzheimer's disease	7.88e-05	0.00128	CbGpPWpGaD
Gabapentin—Hypotension—Rivastigmine—Alzheimer's disease	7.78e-05	0.000344	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Memantine—Alzheimer's disease	7.75e-05	0.000343	CcSEcCtD
Gabapentin—BCAT1—Metabolism—ENO1—Alzheimer's disease	7.73e-05	0.00126	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTGS1—Alzheimer's disease	7.73e-05	0.00126	CbGpPWpGaD
Gabapentin—Feeling abnormal—Donepezil—Alzheimer's disease	7.72e-05	0.000342	CcSEcCtD
Gabapentin—Insomnia—Memantine—Alzheimer's disease	7.69e-05	0.000341	CcSEcCtD
Gabapentin—Vomiting—Galantamine—Alzheimer's disease	7.69e-05	0.00034	CcSEcCtD
Gabapentin—Gastrointestinal pain—Donepezil—Alzheimer's disease	7.66e-05	0.000339	CcSEcCtD
Gabapentin—Paraesthesia—Memantine—Alzheimer's disease	7.64e-05	0.000338	CcSEcCtD
Gabapentin—Rash—Galantamine—Alzheimer's disease	7.62e-05	0.000337	CcSEcCtD
Gabapentin—Dermatitis—Galantamine—Alzheimer's disease	7.61e-05	0.000337	CcSEcCtD
Gabapentin—Dyspnoea—Memantine—Alzheimer's disease	7.58e-05	0.000336	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	7.58e-05	0.000336	CcSEcCtD
Gabapentin—BCAT1—Metabolism—CYP2D6—Alzheimer's disease	7.58e-05	0.00123	CbGpPWpGaD
Gabapentin—Headache—Galantamine—Alzheimer's disease	7.57e-05	0.000335	CcSEcCtD
Gabapentin—Somnolence—Memantine—Alzheimer's disease	7.56e-05	0.000335	CcSEcCtD
Gabapentin—Insomnia—Rivastigmine—Alzheimer's disease	7.53e-05	0.000333	CcSEcCtD
Gabapentin—Dyspepsia—Memantine—Alzheimer's disease	7.49e-05	0.000332	CcSEcCtD
Gabapentin—Paraesthesia—Rivastigmine—Alzheimer's disease	7.47e-05	0.000331	CcSEcCtD
Gabapentin—Urticaria—Donepezil—Alzheimer's disease	7.44e-05	0.00033	CcSEcCtD
Gabapentin—Dyspnoea—Rivastigmine—Alzheimer's disease	7.42e-05	0.000328	CcSEcCtD
Gabapentin—Body temperature increased—Donepezil—Alzheimer's disease	7.41e-05	0.000328	CcSEcCtD
Gabapentin—Abdominal pain—Donepezil—Alzheimer's disease	7.41e-05	0.000328	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	7.4e-05	0.0012	CbGpPWpGaD
Gabapentin—Somnolence—Rivastigmine—Alzheimer's disease	7.4e-05	0.000328	CcSEcCtD
Gabapentin—Decreased appetite—Memantine—Alzheimer's disease	7.39e-05	0.000327	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Memantine—Alzheimer's disease	7.34e-05	0.000325	CcSEcCtD
Gabapentin—Fatigue—Memantine—Alzheimer's disease	7.33e-05	0.000325	CcSEcCtD
Gabapentin—Dyspepsia—Rivastigmine—Alzheimer's disease	7.32e-05	0.000324	CcSEcCtD
Gabapentin—Constipation—Memantine—Alzheimer's disease	7.27e-05	0.000322	CcSEcCtD
Gabapentin—Pain—Memantine—Alzheimer's disease	7.27e-05	0.000322	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	7.24e-05	0.00118	CbGpPWpGaD
Gabapentin—Decreased appetite—Rivastigmine—Alzheimer's disease	7.23e-05	0.00032	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—GAL—Alzheimer's disease	7.21e-05	0.00117	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—BCHE—Alzheimer's disease	7.18e-05	0.00117	CbGpPWpGaD
Gabapentin—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	7.18e-05	0.000318	CcSEcCtD
Gabapentin—Nausea—Galantamine—Alzheimer's disease	7.18e-05	0.000318	CcSEcCtD
Gabapentin—Fatigue—Rivastigmine—Alzheimer's disease	7.17e-05	0.000318	CcSEcCtD
Gabapentin—Constipation—Rivastigmine—Alzheimer's disease	7.12e-05	0.000315	CcSEcCtD
Gabapentin—Pain—Rivastigmine—Alzheimer's disease	7.12e-05	0.000315	CcSEcCtD
Gabapentin—Feeling abnormal—Memantine—Alzheimer's disease	7.01e-05	0.00031	CcSEcCtD
Gabapentin—Gastrointestinal pain—Memantine—Alzheimer's disease	6.96e-05	0.000308	CcSEcCtD
Gabapentin—Hypersensitivity—Donepezil—Alzheimer's disease	6.9e-05	0.000306	CcSEcCtD
Gabapentin—Feeling abnormal—Rivastigmine—Alzheimer's disease	6.86e-05	0.000304	CcSEcCtD
Gabapentin—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	6.8e-05	0.000301	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PLCB1—Alzheimer's disease	6.78e-05	0.0011	CbGpPWpGaD
Gabapentin—Urticaria—Memantine—Alzheimer's disease	6.76e-05	0.000299	CcSEcCtD
Gabapentin—Body temperature increased—Memantine—Alzheimer's disease	6.72e-05	0.000298	CcSEcCtD
Gabapentin—Abdominal pain—Memantine—Alzheimer's disease	6.72e-05	0.000298	CcSEcCtD
Gabapentin—Asthenia—Donepezil—Alzheimer's disease	6.72e-05	0.000298	CcSEcCtD
Gabapentin—Pruritus—Donepezil—Alzheimer's disease	6.63e-05	0.000293	CcSEcCtD
Gabapentin—Urticaria—Rivastigmine—Alzheimer's disease	6.61e-05	0.000293	CcSEcCtD
Gabapentin—Abdominal pain—Rivastigmine—Alzheimer's disease	6.58e-05	0.000291	CcSEcCtD
Gabapentin—Body temperature increased—Rivastigmine—Alzheimer's disease	6.58e-05	0.000291	CcSEcCtD
Gabapentin—BCAT1—Metabolism—ABCA1—Alzheimer's disease	6.57e-05	0.00107	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GAL—Alzheimer's disease	6.55e-05	0.00106	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CHAT—Alzheimer's disease	6.44e-05	0.00105	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TPI1—Alzheimer's disease	6.44e-05	0.00105	CbGpPWpGaD
Gabapentin—Diarrhoea—Donepezil—Alzheimer's disease	6.41e-05	0.000284	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—TTR—Alzheimer's disease	6.38e-05	0.00104	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	6.35e-05	0.00103	CbGpPWpGaD
Gabapentin—Hypersensitivity—Memantine—Alzheimer's disease	6.27e-05	0.000277	CcSEcCtD
Gabapentin—Dizziness—Donepezil—Alzheimer's disease	6.19e-05	0.000274	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—MAOB—Alzheimer's disease	6.18e-05	0.001	CbGpPWpGaD
Gabapentin—Hypersensitivity—Rivastigmine—Alzheimer's disease	6.13e-05	0.000271	CcSEcCtD
Gabapentin—Asthenia—Memantine—Alzheimer's disease	6.1e-05	0.00027	CcSEcCtD
Gabapentin—Pruritus—Memantine—Alzheimer's disease	6.02e-05	0.000266	CcSEcCtD
Gabapentin—Asthenia—Rivastigmine—Alzheimer's disease	5.97e-05	0.000264	CcSEcCtD
Gabapentin—Vomiting—Donepezil—Alzheimer's disease	5.96e-05	0.000264	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—GAPDH—Alzheimer's disease	5.95e-05	0.000966	CbGpPWpGaD
Gabapentin—Rash—Donepezil—Alzheimer's disease	5.91e-05	0.000262	CcSEcCtD
Gabapentin—Dermatitis—Donepezil—Alzheimer's disease	5.9e-05	0.000261	CcSEcCtD
Gabapentin—Pruritus—Rivastigmine—Alzheimer's disease	5.89e-05	0.000261	CcSEcCtD
Gabapentin—Headache—Donepezil—Alzheimer's disease	5.87e-05	0.00026	CcSEcCtD
Gabapentin—Diarrhoea—Memantine—Alzheimer's disease	5.82e-05	0.000258	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—A2M—Alzheimer's disease	5.74e-05	0.000933	CbGpPWpGaD
Gabapentin—Diarrhoea—Rivastigmine—Alzheimer's disease	5.69e-05	0.000252	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PPARGC1A—Alzheimer's disease	5.66e-05	0.00092	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—NPY—Alzheimer's disease	5.66e-05	0.00092	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	5.66e-05	0.000919	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HMOX1—Alzheimer's disease	5.64e-05	0.000916	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCR5—Alzheimer's disease	5.63e-05	0.000915	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IAPP—Alzheimer's disease	5.63e-05	0.000914	CbGpPWpGaD
Gabapentin—Dizziness—Memantine—Alzheimer's disease	5.62e-05	0.000249	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—MAPK8—Alzheimer's disease	5.61e-05	0.000911	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PYY—Alzheimer's disease	5.58e-05	0.000907	CbGpPWpGaD
Gabapentin—Nausea—Donepezil—Alzheimer's disease	5.56e-05	0.000246	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—HTR2A—Alzheimer's disease	5.51e-05	0.000896	CbGpPWpGaD
Gabapentin—Dizziness—Rivastigmine—Alzheimer's disease	5.5e-05	0.000244	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CRH—Alzheimer's disease	5.46e-05	0.000888	CbGpPWpGaD
Gabapentin—Vomiting—Memantine—Alzheimer's disease	5.41e-05	0.000239	CcSEcCtD
Gabapentin—Rash—Memantine—Alzheimer's disease	5.36e-05	0.000237	CcSEcCtD
Gabapentin—Dermatitis—Memantine—Alzheimer's disease	5.36e-05	0.000237	CcSEcCtD
Gabapentin—Headache—Memantine—Alzheimer's disease	5.33e-05	0.000236	CcSEcCtD
Gabapentin—Vomiting—Rivastigmine—Alzheimer's disease	5.29e-05	0.000234	CcSEcCtD
Gabapentin—Rash—Rivastigmine—Alzheimer's disease	5.25e-05	0.000232	CcSEcCtD
Gabapentin—Dermatitis—Rivastigmine—Alzheimer's disease	5.24e-05	0.000232	CcSEcCtD
Gabapentin—Headache—Rivastigmine—Alzheimer's disease	5.21e-05	0.000231	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—NPS—Alzheimer's disease	5.18e-05	0.000842	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LPL—Alzheimer's disease	5.16e-05	0.000838	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—NPY—Alzheimer's disease	5.14e-05	0.000836	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IAPP—Alzheimer's disease	5.11e-05	0.00083	CbGpPWpGaD
Gabapentin—Nausea—Memantine—Alzheimer's disease	5.05e-05	0.000224	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—ACHE—Alzheimer's disease	5e-05	0.000812	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CRH—Alzheimer's disease	4.96e-05	0.000806	CbGpPWpGaD
Gabapentin—Nausea—Rivastigmine—Alzheimer's disease	4.94e-05	0.000219	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—GAB2—Alzheimer's disease	4.94e-05	0.000803	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—SST—Alzheimer's disease	4.94e-05	0.000803	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—INPP5D—Alzheimer's disease	4.94e-05	0.000803	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDK5—Alzheimer's disease	4.84e-05	0.000786	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—F2—Alzheimer's disease	4.83e-05	0.000785	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—APP—Alzheimer's disease	4.81e-05	0.000782	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—NPS—Alzheimer's disease	4.7e-05	0.000764	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS1—Alzheimer's disease	4.68e-05	0.000761	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ENO1—Alzheimer's disease	4.68e-05	0.000761	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PPP3CA—Alzheimer's disease	4.68e-05	0.00076	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HTR6—Alzheimer's disease	4.66e-05	0.000757	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—MTHFR—Alzheimer's disease	4.64e-05	0.000754	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP2D6—Alzheimer's disease	4.59e-05	0.000746	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PLCB1—Alzheimer's disease	4.54e-05	0.000738	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—SST—Alzheimer's disease	4.49e-05	0.000729	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GAB2—Alzheimer's disease	4.49e-05	0.000729	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—APP—Alzheimer's disease	4.37e-05	0.00071	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—BCHE—Alzheimer's disease	4.35e-05	0.000707	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CALM1—Alzheimer's disease	4.34e-05	0.000705	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOE—Alzheimer's disease	4.32e-05	0.000702	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCL2—Alzheimer's disease	4.31e-05	0.0007	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CAV1—Alzheimer's disease	4.28e-05	0.000696	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PSENEN—Alzheimer's disease	4.23e-05	0.000687	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APH1A—Alzheimer's disease	4.17e-05	0.000677	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PLCB1—Alzheimer's disease	4.13e-05	0.00067	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PLCB1—Alzheimer's disease	4.11e-05	0.000667	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NCSTN—Alzheimer's disease	4.06e-05	0.00066	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCA1—Alzheimer's disease	3.98e-05	0.000647	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LRP1—Alzheimer's disease	3.96e-05	0.000643	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—Alzheimer's disease	3.91e-05	0.000636	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GAL—Alzheimer's disease	3.87e-05	0.000628	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GFAP—Alzheimer's disease	3.87e-05	0.000628	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPARG—Alzheimer's disease	3.76e-05	0.000612	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—INS—Alzheimer's disease	3.69e-05	0.0006	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—Alzheimer's disease	3.58e-05	0.000582	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARGC1A—Alzheimer's disease	3.43e-05	0.000558	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HMOX1—Alzheimer's disease	3.42e-05	0.000555	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—A2M—Alzheimer's disease	3.41e-05	0.000554	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PRKCG—Alzheimer's disease	3.36e-05	0.000546	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PSEN2—Alzheimer's disease	3.3e-05	0.000536	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NOS3—Alzheimer's disease	3.24e-05	0.000526	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CCR5—Alzheimer's disease	3.18e-05	0.000517	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LPL—Alzheimer's disease	3.12e-05	0.000508	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—HTR2A—Alzheimer's disease	3.12e-05	0.000506	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PRKCG—Alzheimer's disease	3.05e-05	0.000496	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NPY—Alzheimer's disease	3.04e-05	0.000494	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IAPP—Alzheimer's disease	3.02e-05	0.000491	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTGS2—Alzheimer's disease	2.96e-05	0.000481	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CRH—Alzheimer's disease	2.93e-05	0.000476	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCR5—Alzheimer's disease	2.89e-05	0.00047	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HTR2A—Alzheimer's disease	2.83e-05	0.00046	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MTHFR—Alzheimer's disease	2.81e-05	0.000457	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NPS—Alzheimer's disease	2.78e-05	0.000451	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PPP3CA—Alzheimer's disease	2.76e-05	0.000449	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—F2—Alzheimer's disease	2.73e-05	0.000444	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTK2B—Alzheimer's disease	2.72e-05	0.000443	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GAB2—Alzheimer's disease	2.65e-05	0.000431	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NTRK2—Alzheimer's disease	2.65e-05	0.000431	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SST—Alzheimer's disease	2.65e-05	0.000431	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CALM1—Alzheimer's disease	2.64e-05	0.000429	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CALM1—Alzheimer's disease	2.63e-05	0.000427	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GSK3A—Alzheimer's disease	2.63e-05	0.000427	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOE—Alzheimer's disease	2.62e-05	0.000425	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CAV1—Alzheimer's disease	2.59e-05	0.000422	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APP—Alzheimer's disease	2.58e-05	0.00042	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—F2—Alzheimer's disease	2.48e-05	0.000403	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PLCB1—Alzheimer's disease	2.44e-05	0.000396	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARG—Alzheimer's disease	2.28e-05	0.000371	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NGFR—Alzheimer's disease	2.27e-05	0.00037	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CREB1—Alzheimer's disease	2.26e-05	0.000367	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—INS—Alzheimer's disease	2.24e-05	0.000364	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADAM10—Alzheimer's disease	2.22e-05	0.000361	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL2—Alzheimer's disease	2.21e-05	0.000359	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—S100B—Alzheimer's disease	2.1e-05	0.000341	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF2—Alzheimer's disease	2e-05	0.000325	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NOS3—Alzheimer's disease	1.96e-05	0.000319	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF1R—Alzheimer's disease	1.93e-05	0.000314	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LPL—Alzheimer's disease	1.85e-05	0.000301	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MEF2C—Alzheimer's disease	1.84e-05	0.000299	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKCG—Alzheimer's disease	1.8e-05	0.000293	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS2—Alzheimer's disease	1.79e-05	0.000292	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NGF—Alzheimer's disease	1.76e-05	0.000285	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCR5—Alzheimer's disease	1.71e-05	0.000278	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HTR2A—Alzheimer's disease	1.67e-05	0.000272	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CALM1—Alzheimer's disease	1.56e-05	0.000253	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOE—Alzheimer's disease	1.55e-05	0.000252	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LEP—Alzheimer's disease	1.55e-05	0.000252	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CAV1—Alzheimer's disease	1.54e-05	0.00025	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKT1—Alzheimer's disease	1.49e-05	0.000242	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ESR1—Alzheimer's disease	1.48e-05	0.000241	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—F2—Alzheimer's disease	1.47e-05	0.000238	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.43e-05	0.000233	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GSK3B—Alzheimer's disease	1.35e-05	0.000219	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CREB1—Alzheimer's disease	1.33e-05	0.000217	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—INS—Alzheimer's disease	1.33e-05	0.000216	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL2—Alzheimer's disease	1.31e-05	0.000212	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF1—Alzheimer's disease	1.28e-05	0.000209	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOS3—Alzheimer's disease	1.16e-05	0.000189	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—Alzheimer's disease	9.97e-06	0.000162	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP3—Alzheimer's disease	9.88e-06	0.000161	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—Alzheimer's disease	9.82e-06	0.00016	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK8—Alzheimer's disease	9.08e-06	0.000148	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—Alzheimer's disease	9.06e-06	0.000147	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—Alzheimer's disease	9.02e-06	0.000147	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—Alzheimer's disease	8.39e-06	0.000136	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFB1—Alzheimer's disease	7.7e-06	0.000125	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TP53—Alzheimer's disease	6.34e-06	0.000103	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—Alzheimer's disease	5.8e-06	9.43e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—Alzheimer's disease	5.35e-06	8.7e-05	CbGpPWpGaD
